Immuron (IMRN) Operating Expenses (2016 - 2024)
Immuron (IMRN) recorded quarterly Operating Expenses of -$1296.2 billion in Q4 2024, down 28164652.89% quarter-over-quarter from -$4.6 million in Q4 2023, and down 28164652.89% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Operating Expenses (2016 - 2024) Analysis & Trends
Immuron's Operating Expenses history runs 9 years deep, the most recent figure standing at -$1296.2 billion for Q4 2024.
- In Q4 2024, Operating Expenses fell 28164652.89% year-over-year to -$1296.2 billion; the TTM figure through Sep 2025 stood at -$1296.2 billion (down 28164652.89% YoY), while the FY2025 annual figure was $5.3 million, down 19.47% from the prior year.
- Operating Expenses was -$1296.2 billion for Q4 2024 at Immuron, down from -$4.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of -$15045.1 in Q4 2021 to a low of -$1296.2 billion in Q4 2024.
- Historically, Operating Expenses has averaged -$216.0 billion across 5 years, with a median of -$243851.7 in 2020.
- The sharpest annual moves came in 2021 and 2024: Operating Expenses surged 48.57% in 2021, then tumbled 28164652.89% in 2024.
- A 5-year view of Operating Expenses shows it stood at -$29252.9 in 2020, then soared by 48.57% to -$15045.1 in 2021, then plunged by 47.67% to -$22217.3 in 2022, then plunged by 20615.01% to -$4.6 million in 2023, then sank by 28164652.89% to -$1296.2 billion in 2024.
- The last three Operating Expenses figures came in at -$1296.2 billion (Q4 2024), -$4.6 million (Q4 2023), and -$458450.5 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,296.23 Bn |
| Dec 31, 2023 | -4.60 Mn |
| Jun 30, 2023 | -458,450.49 |
| Dec 31, 2022 | -22,217.30 |
| Dec 31, 2021 | -15,045.11 |
| Dec 31, 2020 | -29,252.94 |
| Dec 31, 2019 | -30,162.89 |
| Dec 31, 2018 | -2.38 Mn |
| Dec 31, 2017 | -3.27 Mn |
| Dec 31, 2016 | -2.19 Mn |
| Jun 30, 2016 | -3.69 Mn |